A Novel Surgical Strategy to Reduce Major Complications in Patients With Necrotizing Pancreatitis: A Retrospective Cohort Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Acute Pancreatitis
- Sponsor
- Tianjin Nankai Hospital
- Enrollment
- 271
- Locations
- 1
- Primary Endpoint
- major complications
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The goal of this observational study is to compare patient outcomes between the groups of patients admitted before and after the full implementation of the novel surgical strategy in patients with necrotizing pancreatitis. The main question it aims to answer are:
• the efficacy and safety of the novel surgical strategy To assess the efficacy and safety of the novel surgical strategy, all included patients were divided into two groups according to the timing of receiving treatment: 1) the early period group: patients admitted before January 2021 received the hybrid strategy of traditional and novel surgical strategies; and 2) the late period group: patients admitted during and after January 2021 received the complete novel surgical strategy.
Investigators
Yang Yang
Resident physicians
Tianjin Nankai Hospital
Eligibility Criteria
Inclusion Criteria
- •Consecutive patients older than 18 years with necrotizing pancreatitis were included.
Exclusion Criteria
- •Patients who met one or more of the following criteria were excluded: (1) had a past medical history of acute pancreatitis; (2) had drainage or surgery for pancreatic necrosis in other hospitals before admission to our institute; and (3) did not complete the treatment strategy owing to nonmedical reasons.
Outcomes
Primary Outcomes
major complications
Time Frame: 90-day follow up
Secondary Outcomes
- Admission of ICU(up to 90-days)
- mortality(90-day follow up)
- individual major complications(90-day follow up)
- Length of hospital stay(up to 90-days)